Concepedia

Masahiro Fukunaga

MF

Statistics

Publications

4

Citations

136

H-Index

4

Active since

1997

Affiliations

Drug Discovery Laboratory (Norway)(Current)

Masahiro Fukunaga is an author at Drug Discovery Laboratory (Norway) specializing in pharmacotherapy, natural sciences, and drug discovery.

Top concepts

Publications per year

1997–2011

4

Publications

4

Studies on Mechanisms of Low Emetogenicity of YM976, a Novel Phosphodiesterase Type 4 Inhibitor

Motonori Aoki, Masahiro Fukunaga, Tohru Sugimoto et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 47 citations

Pharmacological Profile of Celecoxib, a Specific Cyclooxygenase-2 Inhibitor

Taiji Yoshino, Aishi Kimoto, Seiji Kobayashi et al. · Arzneimittelforschung · 2011 · 37 citations

Effect of a Novel Anti-Inflammatory Compound, YM976, on Antigen-Induced Eosinophil Infiltration into the Lungs in Rats, Mice, and Ferrets

Motonori Aoki, Masahiro Fukunaga, M Kitagawa et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 33 citations

3-(13-Hydroxytridecyl)-1-[13-(3-Pyridyl)Tridecyl] Pyridinium Chloride (YM-53792), a Novel Inhibitor of NF-AT activation

Sadao Kuromitsu, Masahiro Fukunaga, Andrew C. Lennard et al. · Biochemical Pharmacology · 1997 · 19 citations

, , +9

1–4 of 4